Synonyms:naltrexone, 16590-41-3, Vivitrol, ReVia, Celupan, N-Cyclopropylmethylnoroxymorphone, Vivitrex, Naltrexona, Nemexin, 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one, N-Cyclopropylmethyl-14-hydroxydihydromorphinone, 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one, 5S6W795CQM, CHEBI:7465, EN-1639A FREE BASE, DTXSID4046313, NSC-758439, (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one, UM-792, EN-1639A [AS HYDROCHLORIDE], Naltrexonum [INN-Latin], (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one, (4R,4As,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one, Naltrexona [INN-Spanish], DTXCID2026313, Naltrexonum, Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-, Naltrexone [USAN:INN:BAN], Naltrexone base anhydrous, CAS-16590-41-3, CCRIS 3506, HSDB 6750, EINECS 240-649-9, BRN 3596648, UNII-5S6W795CQM, (-)naltrexone, PTI-555, NCGC00162274-02, (-)-Naltrexone, Vivitrol (TN), NALTREXONE [MI], NALTREXONE [INN], (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride, Naltrexone (USAN/INN), Prestwick0_000116, Prestwick1_000116, Prestwick2_000116, Prestwick3_000116, NALTREXONE [HSDB], NALTREXONE [USAN], NALTREXONE [VANDF], Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-, NALTREXONE [MART.], NALTREXONE [USP-RS], NALTREXONE [WHO-DD], US9107954, naltrexone, SCHEMBL34681, BSPBio_000132, BIDD:GT0405, CHEMBL19019, SPBio_002071, BPBio1_000146, GTPL1639, NALTREXONE [ORANGE BOOK], BDBM60212, cid_5485201, cyclopropylmethyl(dihydroxy)[?]one, HMS2089O11, BCP07022, EX-A4863, Tox21_112007, BDBM50000787, MFCD00242996, PDSP2_000847, AKOS015994596, Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-, Tox21_112007_1, CS-0880, DB00704, HS-0002, NALTREXONE COMPONENT OF CONTRAVE, NSC 758439, SMP1_000206, NCGC00024427-03, NCGC00024427-04, NCGC00024427-05, AC-36726, HY-76711, C07253, D05113, AB00174152-14, AB00174152_17, AR-270/43507956, EN300-19748946, Q409587, BRD-K88172511-003-21-1, BRD-K88172511-310-03-8, 3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one, 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-, (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride, (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one, (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one, 4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadeca-7(18),8,10-trien-14-one
Pubchem:PUBCHEM:5360515
Id:996bb2c1-9d65-575f-af5a-b268e683f515
Description:nan
